Systematic literature review (SLR) and network meta-analysis (NMA) of first-line therapies (1L) for locally advanced/metastatic urothelial carcinoma (la/mUC).

被引：1
|
作者：
Bloudek, Lisa [1 ]
Hepp, Zsolt [1 ]
Mckay, Caroline [1 ]
Derleth, Christina Louise [1 ]
Lill, Jennifer Susan [1 ]
Lenero, Enrique [1 ]
Wright, Phoebe [1 ]
Ramsey, Scott David [1 ]
Sullivan, Sean D. [1 ]
Devine, Beth [1 ]
机构：
[1] Curta Inc, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
570
引用
收藏
页数：3
相关论文
共 50 条
  • [21] IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
    Bellmunt, J.
    Balar, A.
    Galsky, M. D.
    Loriot, Y.
    Theodore, C.
    Grande Pulido, E.
    Castellano, D.
    Retz, M.
    Niegisch, G.
    Bracarda, S.
    Necchi, A.
    Vaishampayan, U.
    Sridhar, S.
    Eigl, B. J.
    Hussain, S.
    van der Heijden, M.
    Danner, B.
    Mariathasan, S.
    Legrand, F.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] SINTILIMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC NONSQUAMOUS NON-SMALL-CELL LUNG CANCER (AMNSQNSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR) AND NETWORK META-ANALYSIS (NMA)
    Garassino, M.
    Brnabic, A.
    Stefaniak, V
    Belger, M.
    Gruver, K.
    Chen, J., V
    Souri, S.
    Molife, C.
    Blumenschein, G.
    VALUE IN HEALTH, 2022, 25 (07) : S307 - S307
  • [23] SURVIVAL ANALYSES AND INDIRECT TREATMENT COMPARISONS (ITCS) IN FIRST-LINE METASTATIC UROTHELIAL CARCINOMA (1L MUC)
    Jevdjevic, M.
    Nickel, K.
    Teitsson, S.
    Kurt, M.
    Broughton, E.
    Jain, R.
    Kroep, S.
    VALUE IN HEALTH, 2022, 25 (07) : S333 - S333
  • [24] First-line (1L) enfortumab vedotin plus pembrolizumab demonstrates durable antitumour activity in cisplatin-ineligible patients with locally advanced/metastatic urothelial carcinoma (la/mUC)
    Rosenberg, J. E.
    Flaig, T. W.
    Friedlander, T. W.
    Milowsky, M. I.
    Srinivas, S.
    Petrylak, D. P.
    Merchan, J. R.
    Bilen, M. A.
    Carret, A. -S.
    Yuan, N.
    Sasse, C.
    Hoimes, C. J.
    SWISS MEDICAL WEEKLY, 2020, : 26S - 27S
  • [25] First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis
    Petrelli, Fausto
    Riboldi, Valentina
    Bruschieri, Lorenza
    Villa, Antonella
    Cribiu', Fulvia Milena
    Borgonovo, Karen
    Ghilardi, Mara
    Ghidini, Antonio
    Seghezzi, Silvia
    De Stefani, Agostina
    Trevisan, Francesca
    CANCER TREATMENT REVIEWS, 2025, 135
  • [26] The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis
    Peng, Wei
    Pan, Yangxun
    Xie, Lan
    Yang, Zhoutian
    Ye, Zhiwei
    Chen, Jinbin
    Wang, Juncheng
    Hu, Dandan
    Xu, Li
    Zhou, Zhongguo
    Chen, Minshan
    Fang, Aiping
    Zhang, Yaojun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [27] PEMBROLIZUMAB PLUS AXITINIB (P plus A) VERSUS OTHER FIRST-LINE (1L) SYSTEMIC THERAPIES FOR ADVANCED/METASTATIC CLEAR-CELL RENAL CELL CARCINOMA (CCMRCC) - A NETWORK META-ANALYSIS (NMA)
    McGovern, I
    Simon, A.
    Shirali, R.
    Zhong, Y.
    Perini, R.
    Lorenzi, M.
    Adejoro, O.
    VALUE IN HEALTH, 2019, 22 : S444 - S444
  • [28] CLINICAL OUTCOMES OF FIRST-LINE (1L) TREATMENTS (Txs) IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (aNSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Reck, M.
    Soo, R. A.
    Coaquira, Castro J.
    Chaudhary, T.
    Finn, E.
    Xu, W.
    Zhan, L.
    VALUE IN HEALTH, 2024, 27 (06) : S44 - S44
  • [29] Network meta-analysis (NMA) of pembrolizumab for first-line (1L) treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
    Ramakrishnan, Karthik
    Mojebi, Ali
    Ayers, Dieter
    Chirovsky, Diana Romana
    Borse, Rebekah
    Keeping, Sam
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis
    O'Dwyer, Richard
    Musat, Mihaela G.
    Gulas, Ioana
    Hubscher, Elizabeth
    Moradian, Hoora
    Guenther, Silke
    Kearney, Mairead
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
12345